Open Access

[Retracted] MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator

  • Authors:
    • Aihong Jiao
    • Minghua Sui
    • Liangming Zhang
    • Ping Sun
    • Dongmei Geng
    • Weiwei Zhang
    • Xiuwen Wang
    • Junxia Li
  • View Affiliations

  • Published online on: June 8, 2021     https://doi.org/10.3892/mmr.2021.12212
  • Article Number: 573
  • Copyright : © Jiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

August-2021
Volume 24 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiao A, Sui M, Zhang L, Sun P, Geng D, Zhang W, Wang X and Li J: [Retracted] MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator. Mol Med Rep 24: 573, 2021
APA
Jiao, A., Sui, M., Zhang, L., Sun, P., Geng, D., Zhang, W. ... Li, J. (2021). [Retracted] MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator. Molecular Medicine Reports, 24, 573. https://doi.org/10.3892/mmr.2021.12212
MLA
Jiao, A., Sui, M., Zhang, L., Sun, P., Geng, D., Zhang, W., Wang, X., Li, J."[Retracted] MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator". Molecular Medicine Reports 24.2 (2021): 573.
Chicago
Jiao, A., Sui, M., Zhang, L., Sun, P., Geng, D., Zhang, W., Wang, X., Li, J."[Retracted] MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator". Molecular Medicine Reports 24, no. 2 (2021): 573. https://doi.org/10.3892/mmr.2021.12212